Advertisement

Relapse Risk for Psychosis in Dementia Lower With Continued Pimavanserin

0

Findings seen in double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy

Virtual Roller Coaster Ride Used to Study Migraine Symptoms

0

Patients report more dizziness, motion sickness; neuronal activity more pronounced in superior and inferior occipital gyrus, pontine nuclei

Vision Impairment Tied to Cognitive Decline

0

Contrast sensitivity impairment may affect cognitive decline across more domains than other vision measures

2019 to 2020 Saw 1.5-Year Decline in U.S. Life Expectancy at Birth

0

Mortality due to COVID-19 had biggest effect on decline in life expectancy for both men and women, all races examined

Global Prevalence of Young-Onset Dementia Examined

0

Worldwide, an estimated 3.9 million people aged 30 to 64 years are living with young-onset dementia

Intensive BP Control After ICH May Be Risky for Some Patients

0

Intensive BP lowering after intracerebral hemorrhage linked to poorer outcomes in patients with decreased renal function

Almost Half of Patients Admitted With COVID-19 Have Complications

0

Likelihood of having complications higher for men than women and for those aged older than 60 years

COVID-19 Outcomes May Be Worse for People With Learning Disability

0

Risks for COVID-19-related hospital admission, death higher for people with learning disability registered with a general practice in England

Two Major Health Systems Will Not Administer Controversial Aduhelm

0

Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion

Multiple Sclerosis Disease Burden Higher in Black Patients

0

Both self-reported disability and objective assessments worse for Black patients, independent of socioeconomic status